 CELEBRATION, Fla., June 09, 2021 GLOBE NEWSWIRE -- KemPharm, Inc. NASDAQ: KMPH, a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its expected addition to the broad-market Russell 3000 Index and the Russell 2000 Index in accordance with the 2021 Russell indexes annual reconstitution. KemPharms anticipated inclusion in the Russell indexes will be effective after the U.S. market opens on Monday, June 28, 2021. 